Back to Trades
Voss Capital, LP
10% OwnerCIK 0001730145
Total Volume
$53.8M
18 filings
Purchases
$42.3M
83 buy txns
Sales
$10.3M
17 sell txns
Net Activity
$32.0M
net bought
Profile
- Filings
- 18
- Buy transactions
- 83
- Sell transactions
- 17
- Companies
- 4
- Active
- 2025–2026
Voss Capital, LP, 10% Owner, accounts for 18 disclosed filings worth $53.8M, spread across 4 companies, active 2025–2026. The record is net buying, with $42.3M in purchases against $10.3M in sales. The largest single open-market purchase on record is $14.7M in PAR TECHNOLOGY CORP. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
18 loaded
| Sep 22 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Exercise | $1.0M |
| Sep 1 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Sell | $840.8K |
| Aug 28 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Sell | $2.3M |
| Aug 26 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Sell | $5.3M |
| Aug 20 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Sell | $1.9M |
| Jun 15 | PAR PAR TECHNOLOGY CORP | Voss Capital, LP | 10% Owner | Buy | $5.1M |
| May 21 | XPOF Xponential Fitness, Inc. | Voss Capital, LP | 10% Owner | Buy | $963.9K |
| May 18 | PAR PAR TECHNOLOGY CORP | Voss Capital, LP | 10% Owner | Buy | $10.5M |
| Mar 5 | PAR PAR TECHNOLOGY CORP | Voss Capital, LP | 10% Owner | Buy | $14.7M |
| Feb 18 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Buy | $274.8K |
| Jan 7 | PAR PAR TECHNOLOGY CORP | Voss Capital, LP | 10% Owner | Other | $0 |
| Jan 7 | PAR PAR TECHNOLOGY CORP | Voss Capital, LP | 10% Owner | Buy | $7.1M |
| Jan 7 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Other | $0 |
| Jan 7 | FLYW Flywire Corp | Voss Capital, LP | 10% Owner | Buy | $3.2M |
| Nov 18 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Buy | $127.6K |
| Nov 12 | XPOF Xponential Fitness, Inc. | Voss Capital, LP | 10% Owner | Other | $0 |
| Oct 28 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Buy | $423.5K |
| Oct 3 | RNTX Rein Therapeutics, Inc. | Voss Capital, LP | 10% Owner | Other | $0 |
18 filings